- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Large Cap High Growth Potential
Global Pharmaceuticals & Biotech Large Cap High Growth Potential
UPDATED Apr 11, 2024
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
45 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
BGNE | US$146.13 | -2.3% | -45.0% | US$15.6b | US$268.64 | PS6.2x | E56.5% | n/a | ||
TEVA | US$13.87 | -0.4% | 49.8% | US$15.5b | US$15.74 | PB2.1x | E38.4% | 0% | ||
NOVO B | kr.869.30 | 1.0% | 55.7% | kr.3.9t | kr.901.80 | PE46.3x | E14.2% | 1.1% | ||
BMRN | US$91.46 | 5.3% | -7.0% | US$17.1b | US$109.83 | PE103.5x | E30.4% | n/a | ||
REC | €49.10 | -1.4% | 21.8% | €10.1b | €50.84 | PE26x | E9.0% | 2.4% | ||
AVTR | US$25.55 | 1.8% | 18.9% | US$17.4b | US$27.75 | PE54x | E27.2% | n/a | ||
GSK | UK£16.29 | -0.5% | 7.0% | UK£66.6b | UK£20.00 | PE13.5x | E9.4% | 3.6% | ||
NOVN | CHF85.63 | -3.0% | -1.7% | CHF187.5b | CHF98.36 | PE24.1x | E9.1% | 3.8% | ||
ILMN | US$130.70 | 3.7% | -43.8% | US$20.9b | US$160.46 | PS4.6x | E68.5% | n/a | ||
HZNP | US$116.30 | 0.06% | 82.8% | US$26.6b | US$116.50 | PE60.8x | E16.4% | n/a | ||
ROG | CHF226.10 | 0.5% | -18.2% | CHF182.1b | CHF281.28 | PE15.7x | E8.3% | 4.2% | ||
4503 | JP¥1,584.50 | -1.2% | -18.4% | JP¥2.8t | JP¥2,093.33 | PE676.7x | E30.0% | 4.4% | ||
ERF | €60.30 | -1.8% | -3.5% | €11.6b | €59.28 | PE45.2x | E19.7% | 0.8% | ||
CSL | AU$280.40 | -0.6% | -7.2% | AU$135.5b | AU$306.44 | PE35.8x | E14.8% | 1.3% | ||
BAYN | €27.02 | -5.4% | -55.7% | €26.5b | €37.71 | PB0.8x | E43.1% | 0.4% | ||
LONN | CHF540.20 | -1.6% | -7.1% | CHF39.0b | CHF566.00 | PE59.6x | E20.0% | 0.7% | ||
RVTY | US$108.50 | 6.7% | -20.8% | US$13.3b | US$123.11 | PE74.7x | E24.1% | 0.3% | ||
VRTX | US$400.23 | -0.9% | 20.1% | US$102.8b | US$461.27 | PE28.6x | E11.3% | n/a | ||
600436 | CN¥220.10 | -4.5% | -22.0% | CN¥132.8b | CN¥293.53 | PE47.7x | E20.3% | 0.6% | ||
CTLT | US$56.92 | -0.07% | -10.1% | US$10.3b | US$63.50 | PS2.5x | E92.3% | n/a | ||
PFE | US$26.34 | -1.2% | -36.5% | US$149.0b | US$31.62 | PE69.9x | E22.1% | 6.4% |